InvestorsHub Logo
Followers 4
Posts 1194
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 240

Wednesday, 06/29/2016 9:29:02 AM

Wednesday, June 29, 2016 9:29:02 AM

Post# of 977
Moderna and Merck will develop personalized cancer vaccines that utilize Moderna’s mRNA vaccine technology to encode a patient’s specific neoantigens, unique mutations present in that specific patient’s tumor. When injected into a patient, the vaccine will be designed to elicit a specific immune response that will recognize and destroy cancer cells.

http://finance.yahoo.com/news/merck-moderna-announce-strategic-collaboration-110000684.html